Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

itm medical isotopes gmbh - lutetium (177lu) chloride - radionuklidno slikanje - terapevtski radiofarmacevtiki - endolucinbeta je predhodnik radiofarmacevtskega sredstva in ni namenjen neposredni uporabi pri bolnikih. je namenjena le za radioaktivno označevanje prevoznika molekul, ki so bili posebej razviti in dovoljenje za radioaktivno označevanje s kloridom lutecij (177lu).

Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

cis bio international - yttrium (90y) chloride - radionuklidno slikanje - diagnostični radiofarmacevtiki - uporablja se le za radioaktivno označevanje nosilnih molekul, ki so bile posebej razvite in odobrene za radioaktivno označevanje s tem radionuklidom. radiopharmaceutical precursor - not intended for direct application to patients.

Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

advanced accelerator applications - lutecij (177lu) oxodotreotide - neuroendokrine tumorje - drugi terapevtski radiofarmacevtiki - lutathera je indicirano za zdravljenje neoperabilnim ali metastatskim, progressive, dobro diferencirani (g1 in g2), somatostatina receptor pozitivnih gastroenteropancreatic neuroendokrinih tumorjev (gep‑nets) pri odraslih.

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dopharma research -

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eurovet animal health -

Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastična sredstva - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

imetnik dovoljenja za promet zdravilom: beaphar -

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bioveta -

Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zoetis belgium sa rue laid burniat 1 1348 louvain -